183 related articles for article (PubMed ID: 33407513)
1. Hydrophobic insertion-based engineering of tumor cell-derived exosomes for SPECT/NIRF imaging of colon cancer.
Jing B; Gai Y; Qian R; Liu Z; Zhu Z; Gao Y; Lan X; An R
J Nanobiotechnology; 2021 Jan; 19(1):7. PubMed ID: 33407513
[TBL] [Abstract][Full Text] [Related]
2. Extracellular vesicles-based pre-targeting strategy enables multi-modal imaging of orthotopic colon cancer and image-guided surgery.
Jing B; Qian R; Jiang D; Gai Y; Liu Z; Guo F; Ren S; Gao Y; Lan X; An R
J Nanobiotechnology; 2021 May; 19(1):151. PubMed ID: 34022897
[TBL] [Abstract][Full Text] [Related]
3. Multi-antitumor therapy and synchronous imaging monitoring based on exosome.
Qian R; Jing B; Jiang D; Gai Y; Zhu Z; Huang X; Gao Y; Lan X; An R
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2668-2681. PubMed ID: 35091755
[TBL] [Abstract][Full Text] [Related]
4. Improved Cellular Delivery of Antisense Oligonucleotide for miRNA-21 Imaging In Vivo Using Cell-Penetrating Peptide-Based Nanoprobes.
Yang G; Zhao Y; Gong A; Miao W; Yan L; Nie P; Wang Z
Mol Pharm; 2021 Mar; 18(3):787-795. PubMed ID: 33480702
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using (99m)Tc-HMPAO.
Hwang DW; Choi H; Jang SC; Yoo MY; Park JY; Choi NE; Oh HJ; Ha S; Lee YS; Jeong JM; Gho YS; Lee DS
Sci Rep; 2015 Oct; 5():15636. PubMed ID: 26497063
[TBL] [Abstract][Full Text] [Related]
6. Characterization of TCP-1 probes for molecular imaging of colon cancer.
Liu Z; Gray BD; Barber C; Bernas M; Cai M; Furenlid LR; Rouse A; Patel C; Banerjee B; Liang R; Gmitro AF; Witte MH; Pak KY; Woolfenden JM
J Control Release; 2016 Oct; 239():223-30. PubMed ID: 27574992
[TBL] [Abstract][Full Text] [Related]
7. SPECT/NIRF Dual Modality Imaging for Detection of Intraperitoneal Colon Tumor with an Avidin/Biotin Pretargeting System.
Dong C; Yang S; Shi J; Zhao H; Zhong L; Liu Z; Jia B; Wang F
Sci Rep; 2016 Jan; 6():18905. PubMed ID: 26732543
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer.
Shi J; Jia B; Liu Z; Yang Z; Yu Z; Chen K; Chen X; Liu S; Wang F
Bioconjug Chem; 2008 Jun; 19(6):1170-8. PubMed ID: 18491928
[TBL] [Abstract][Full Text] [Related]
9. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
10. Investigations of (99m)Tc-labeled glucarate as a SPECT radiotracer for non-small cell lung cancer (NSCLC) and potential tumor uptake mechanism.
Meng L; Xiu Y; Li Y; Xu X; Li S; Li X; Pak KY; Shi H; Cheng D
Nucl Med Biol; 2015 Jul; 42(7):608-13. PubMed ID: 25890861
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
[TBL] [Abstract][Full Text] [Related]
12. Novel cancer-targeting SPECT/NIRF dual-modality imaging probe (99m)Tc-PC-1007: synthesis and biological evaluation.
Zhang Y; Xiao L; Popovic K; Xie X; Chordia MD; Chung LW; Williams MB; Yue W; Pan D
Bioorg Med Chem Lett; 2013 Dec; 23(23):6350-4. PubMed ID: 24125889
[TBL] [Abstract][Full Text] [Related]
13. PEGylated and Non-PEGylated TCP-1 Probes for Imaging of Colorectal Cancer.
Liu Z; Gray BD; Barber C; Wan L; Furenlid LR; Liang R; Li Z; Woolfenden JM; Pak KY; Martin DR
Mol Imaging Biol; 2023 Feb; 25(1):133-143. PubMed ID: 34845659
[TBL] [Abstract][Full Text] [Related]
14. The Distribution and Imaging of
Fan G; Wan R; Zhang B; Deng S; Peng M; Xue W; Xu L; Qin X; Wu Y
Cancer Biother Radiopharm; 2018 Dec; 33(10):445-459. PubMed ID: 30133308
[No Abstract] [Full Text] [Related]
15. Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with (99m)Tc-peptide-Z(HER2:342).
Zhang J; Zhao X; Wang S; Wang N; Han J; Jia L; Ren X
Nucl Med Biol; 2015 Jun; 42(6):541-6. PubMed ID: 25735223
[TBL] [Abstract][Full Text] [Related]
16. A novel multivalent (99m)Tc-labeled EG2-C4bpα antibody for targeting the epidermal growth factor receptor in tumor xenografts.
Li C; Zhang Y; Wang L; Feng H; Xia X; Ma J; Yuan H; Gao B; Lan X
Nucl Med Biol; 2015 Jun; 42(6):547-54. PubMed ID: 25779037
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Evaluation of Mesothelin-Specific Ligands for SPECT Imaging of Triple-Negative Breast Cancer.
Montemagno C; Bacot S; Ahmadi M; Kerfelec B; Baty D; Debiossat M; Soubies A; Perret P; Riou L; Fagret D; Broisat A; Ghezzi C
J Nucl Med; 2018 Jul; 59(7):1056-1062. PubMed ID: 29572256
[TBL] [Abstract][Full Text] [Related]
18. Improved in Vivo Targeting Capability and Pharmacokinetics of
Gao H; Luo C; Yang G; Du S; Li X; Zhao H; Shi J; Wang F
Bioconjug Chem; 2019 Jul; 30(7):2038-2048. PubMed ID: 31063685
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution characteristics and SPECT imaging of (99m)Tc-RET and (99m)Tc-REG in human lung cancer xenografts.
Xie WH; Zhang B; Wang LH; Liu CY; Chang C; Lei B; Wu YW
Cancer Biother Radiopharm; 2015 Apr; 30(3):117-24. PubMed ID: 25714734
[TBL] [Abstract][Full Text] [Related]
20.
Molavipordanjani S; Khodashenas S; Abedi SM; Moghadam MF; Mardanshahi A; Hosseinimehr SJ
Eur J Pharm Sci; 2020 May; 148():105312. PubMed ID: 32198014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
